FGFR2 and BAP1 alterations commonly co-occur in intrahepatic cholangiocarcinoma41, suggesting that the FGFR2 and BAP1 co-alteration may represent a distinct cooperative molecular etiology for some cancers. The gene discussed is FGFR2; the disease is cancer.